FDA Announces New Division Director for Cardiovascular and Renal Products

Summary

The FDA Center for Drug Evaluation and Research has announced a new division director for the Office of Cardiology, Hematology, Endocrinology, and Nephrology. The appointment is effective immediately. No policy changes anticipated during transition period.